NO164992C - Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper. - Google Patents

Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper.

Info

Publication number
NO164992C
NO164992C NO86860321A NO860321A NO164992C NO 164992 C NO164992 C NO 164992C NO 86860321 A NO86860321 A NO 86860321A NO 860321 A NO860321 A NO 860321A NO 164992 C NO164992 C NO 164992C
Authority
NO
Norway
Prior art keywords
surface protein
binding properties
fibronective
bakerial
procedure
Prior art date
Application number
NO86860321A
Other languages
English (en)
Norwegian (no)
Other versions
NO860321L (no
NO164992B (no
Inventor
Magnus Hoeoek
Kjell Martin Lindberg
Torkel Mikael Wadstroem
Original Assignee
Alfa Laval Agri Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri Int filed Critical Alfa Laval Agri Int
Publication of NO860321L publication Critical patent/NO860321L/no
Publication of NO164992B publication Critical patent/NO164992B/no
Publication of NO164992C publication Critical patent/NO164992C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
NO86860321A 1984-05-30 1986-01-29 Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper. NO164992C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
PCT/SE1985/000227 WO1985005553A1 (en) 1984-05-30 1985-05-30 Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and profylactic treatment

Publications (3)

Publication Number Publication Date
NO860321L NO860321L (no) 1986-01-29
NO164992B NO164992B (no) 1990-08-27
NO164992C true NO164992C (no) 1990-12-05

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86860321A NO164992C (no) 1984-05-30 1986-01-29 Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper.

Country Status (13)

Country Link
EP (1) EP0163623B1 (de)
JP (1) JPH0747541B2 (de)
AT (1) ATE52543T1 (de)
AU (1) AU600886B2 (de)
CA (1) CA1340401C (de)
DE (1) DE3577579D1 (de)
ES (1) ES8900019A1 (de)
FI (1) FI84431C (de)
IE (1) IE59203B1 (de)
NO (1) NO164992C (de)
NZ (1) NZ212244A (de)
SE (1) SE454403B (de)
WO (1) WO1985005553A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
EP0621875B1 (de) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen-bildungsprotein
JPH0840932A (ja) 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
ES2322409T3 (es) * 1998-08-31 2009-06-19 Inhibitex, Inc. Vacunas multicomponentes contra staphylococcus aureus.
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
EA014352B1 (ru) 2005-08-10 2010-10-29 Арне Форсгрен Аб Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента
SA110310528B1 (ar) 2009-06-22 2014-07-02 Wyeth Llc التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
SE8402938L (sv) 1985-12-01
EP0163623A3 (en) 1987-02-25
JPS61502334A (ja) 1986-10-16
IE851337L (en) 1985-11-30
FI860417L (fi) 1986-01-29
EP0163623B1 (de) 1990-05-09
FI84431B (fi) 1991-08-30
NO860321L (no) 1986-01-29
FI84431C (fi) 1991-12-10
JPH0747541B2 (ja) 1995-05-24
DE3577579D1 (de) 1990-06-13
FI860417A0 (fi) 1986-01-29
EP0163623A2 (de) 1985-12-04
SE454403B (sv) 1988-05-02
NO164992B (no) 1990-08-27
ES543635A0 (es) 1988-11-01
IE59203B1 (en) 1994-01-26
ES8900019A1 (es) 1988-11-01
CA1340401C (en) 1999-02-23
SE8402938D0 (sv) 1984-05-30
ATE52543T1 (de) 1990-05-15
AU600886B2 (en) 1990-08-30
WO1985005553A1 (en) 1985-12-19
NZ212244A (en) 1989-03-29

Similar Documents

Publication Publication Date Title
NO164992C (no) Fremgangsmaate for fremstilling av bakerielt overflateprotein med fibronektinbindende egenskaper.
ATE130031T1 (de) Verwendungen viraler enzyme.
DE3789428D1 (de) Mikroorganismen, fähig zur Laktoseassimilation.
DE3071593D1 (en) Thermo-stable micro-organism and proteolytic enzyme prepared therefrom, and processes for the preparation of the micro-organism and the proteolytic enzyme
DE2963289D1 (en) Bacterial beta-galactosidase, immobilized forms thereof, process for their preparation and use in the hydrolysis of lactose, and novel bacteria
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE128814T1 (de) Käseherstellungsverfahren.
IL74552A0 (en) Strains of micro-organisms able to produce l-carnitine and process for the microbiological production of l-carnitine
ATE43500T1 (de) Herstellung von antikoerpern.
DE3066574D1 (en) Optically pure heterocyclic amino acids, process for their preparation and their use
ES475972A1 (es) Produccion de liofilizado de enzimas descompuetas.
EP0020781A4 (de) Verfahren zur herstellung einer lösung eines laktose-spaltungsprodukts.
DK442289A (da) Fremgangsmaade til forhoejelse af enzymaktiviteter og synteseeffekt hos organismer
ATE66343T1 (de) Behandlungsverfahren fuer milch zur erhaltung von kaese.
EP0255299A3 (de) Glykopeptid-Antibiotika
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
Sannabhadti et al. Proteolytic enzymes of lactic starters.
DE69233206D1 (de) Methode zur herstellung rekombinanter proteine und dafür verwendete wirtszellen
TH1345A (de)
DK421386D0 (da) Fremgangsmaade til submers dyrkning af pseudomonas aeruginosa bakteriestammer
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
HUT37343A (en) Process for production of cosmetical and medical preparatives for skin-regeneration